Objectives: Bone regeneration by bone tissue engineering is a therapeutic option for bone defects. Improving the osteogenic differentiation of mesenchymal stem cells (MSCs) is essential for successful bone regeneration. We previously showed that AP2a enhances the osteogenic differentiation in MSCs. The present study investigated the mechanism of how AP2a regulates the direct differentiation.
| INTRODUC TI ON
As the physical support of a man, bone quantity and quality mean a lot to life and health. Numerous bone diseases are about to injure the normal bone structures. Through a century of developing, the surgical resection is still the main treatment to deal with bone tumours, including some cysts, leaving varisized bone defects. [1] [2] [3] The surgeons are devoted to restore the supportive bone in a functional and aesthetic way, and achieve some progress with autografs, allografts and xenografts. However, the reconstruction of some large-scale bone lesions, especially in maxillofacial areas, is inevitable with injuring other portion of the patients' bone, such as the fibulas. And the outcomes are always unsatisfactory. 2, 3 Moreover, bone fractures and osteoporosis usually happened to older patients. More than 30% of peoples over 50 year old are estimated to be attacked by osteoporosis-related fracture. 4 5%-10% of fractures may turn into non-union or delayed union, 5 of which the most severe one, hip fractures, are 15%-25% consequent mortality. 6 Along with the development of bone tissue engineering, tissue engineering strategies come to be an alternative to promote bone healing and the clinical treatment outcomes.
All the three portions, the seed cells, the scaffolds and the signalling molecules, in bone tissue engineering, are investigated widely and showed an enhancement of osteogenic differentiation or bone regeneration to a certain degree. The modification of the commonly used scaffolds, such as HA, β-TCP, polylactic-co-glycolic acid (PLGA) and collagen, were carried out to improve the osteoinduction and osteoconduction. [7] [8] [9] But the β-TCP and porcine collagen were confirmed no better than bovine bone particles used in clinic. 10 The signalling molecules BMPs and PRP have been widely used in clinic. But in larger bone defects, using growth factor alone is far from enough. Due to the tissue affinity, BMSCs are the most classic used seed cells for bone regeneration. 11 In a comparison investigation, dental tissue-derived MSCs were confirmed to have higher proliferation ability than BMSCs, 12 which might be easier to amplify in vitro and gather enough cell quantity for clinic. Among the dental tissue-derived MSCs, SCAPs exhibit the strongest osteogenic capacity compared with PDLSCs, DPSCs, SHED and DFSCs. [12] [13] [14] It was well known that mesenchymal stem cells (MSCs) hold the ability to differentiate into osteogenic cells, and they are generally used as seed cells, the most important part, in bone tissue engineering. Learning about the mechanism of osteogenic differentiation in MSCs helps in improving the results of bone tissue engineering. Our previous study showed that activator protein 2a (AP2a) enhances the osteogenic differentiation potential of MSCs. 15 AP2a is a transcription factor that can either activate or inhibit the expression of downstream gene through generating homodimer or heterodimer. It was confirmed to be an essential regulator in craniofacial development. The AP2a knockout mice developed severe skeletal defects with bone-associated symptoms of craniofacial dismorphogenesis and duplicated limbs, forepaws or fingers. 16, 17 The mutations of AP2a in human develop into the Branchio-Oculo-Facial Syndrome (BOFS) showing orofacial clefting similar with AP2a-null mice. [18] [19] [20] AP2a was also found to suppress chondrogenesis by downregulating the associated key transcription factor Sox5 and Sox6, as well as the matrix protein
Col-II and Col-X. 21 A most recent investigation found that the cooperation of AP2a and AP2b is the major regulator in neural crest development and affects the jaw skeleton patterning through the DLX code. 22 All the studies showed the importance of AP2a in hard tissue differentiation and development. However, the mechanism of AP2a in osteogenic differentiation of MSCs remains unclear.
In the present study, we used dental and non-dental-derived 
| MATERIAL S AND ME THODS

| Cell culture
| Plasmid construction and viral infection
The plasmids were constructed using standard methods and veri- 
| Co-immunoprecipitation assays
The cells were washed twice with PBS and lysed in 500 µL cold 
| Alizarin red staining
Mesenchymal stem cells were grown in mineralization-inducing medium using the STEMPRO Osteogenesis Differentiation Kit (Invitrogen). To detect mineralization potential, cells were induced for 2 or 3 weeks, fixed with 70% ethanol and stained with 2% Alizarin Red (Sigma-Aldrich). To quantitate the calcium mineral content, the stained cells were destained with 10% cetylpyridinium chloride in 10 mmol/L sodium phosphate for 60 minutes at room temperature. The concentration was determined by the absorbance at 562 nm on a multiplate reader using a standard calcium curve in the same solution. The final calcium level in each group was normalized to the total protein concentrations obtained from a duplicate plate.
| Reverse transcriptase polymerase chain reaction (RT-PCR) and real-time RT-PCR
Total RNA was extracted from MSCs using Trizol reagent (Invitrogen). The cDNA was synthesized from 2 µg aliquots of RNA, random hexamers or oligo(dT), and reverse transcriptase according to the manufacturer's protocol (Invitrogen). Real-time PCR reactions were carried out using the QuantiTect SYBR Green PCR kit (Qiagen, Hilden, Germany) and an Icycler iQ Multi-colour Real-time PCR Detection System. The primers for specific genes are listed in Table S1 . ratio (v/w) of reagent to DNA. Luciferase assays were performed using a dual-luciferase reporter assay system (Promega) 48 hours after transfection. All reporter assays were normalized to Renilla.
| Luciferase assay
| ChIP assays
The ChIP assay kit (Merck Millipore, Billerica, MA, USA) was used Table S2 .
| Transplantation in nude mice
The present study was censored and approved by the Animal Care and Use Committee of Capital Medical University, Beijing, China. 
| Immunohistochemistry staining
| RE SULTS
| YAP associated with AP2a and formed protein complex in MSCs
We over-expressed YAP in SCAPs using retrovirus expressing wildtype YAP with a Myc tag. After selection with 400 μg/mL hygromy- 
| YAP inhibited the osteogenic differentiation of MSCs in vitro and in vivo
The osteogenic differentiation potentials of SCAPs were exam- 
| AP2a competed with RUNX2 for binding with YAP
We examined the association of RUNX2 with YAP in SCAPs and 
| AP2a-YAP protein complex directly inhibited the transcription of BARX1 in MSCs
Next, we investigated the potential downstream gene of AP2a. We analysed the promoter of a transcription factor, BARX1, and uncovered five AP2a-binding sites ( Figure S2 ). And then, SCAPs were infected with retrovirus expressing wild-type BCOR with a Flag tag.
After selected with 600 μg/mL G418 for 14 days, Western blot results confirmed that BCOR was ectopically expressed in SCAPs 
| D ISCUSS I ON
Our previous study showed that AP2a enhances osteogenic differentiation in MSCs. 15 To elucidate the underlying mechanism, we analysed the protein structure of transcription factor AP2a and found a PY motif, which is essential for transcriptional activation.
Another protein module, the WW domain, could recognize and bind the PY motif to mediate protein-protein interactions. [24] [25] [26] [27] By protein structure analysis, we noticed that YAP had a WW domain. Using yeast two-hybrid screening, YAP has been shown to associate with the PY motif of PEBP2a through its WW domain. 28 Previously, YAP was confirmed to inhibit the osteogenic activity of osteoblasts. 29, 30 Moreover, the physical stimulations, including hierarchical structure, acoustic tweezing cytometry, gold nanoparticles, grid topology, could enhance the osteogenesis through YAP activation. Next, we want to figure out the target of AP2a/YAP protein complex in osteogenic differentiation regulation in MSCs. In our previous studies, AP2a is a direct target of BCOR and negatively regulated by BCOR via epigenetic regulation. 15 And AP2a
was reported to regulate some homeobox genes. 35 Our previous microarray results showed that homeobox gene BARX1 is downregulated in BCOR mutant SCAPs compared to wild-type SCAPs.
15
As a transcription factor, BARX1 expresses in the mesenchyme and plays a crucial role in craniofacial mesenchyme development.
36,37
In the mouse, the pharyngeal arches, limb buds, developing joints, molar tooth papillae and the stomach wall, where the mesenchymal condensation is located, exhibit significant Barx1 expression. [38] [39] [40] Some joint and craniofacial anomalies in humans are also caused by rare duplications and deletions of BARX1. [41] [42] [43] 44 These findings suggested that BARX1 may be regulated by AP2a directly. In present study, we found that the expression of BARX1 was decreased after overexpressing AP2a in MSCs, and luciferase and ChIP assay results confirmed that AP2a downregulated the transcription of BARX1
by directly binding the BARX1 promoter, confirmed that AP2a is a direct regulator of BARX1. These results suggest that BARX1 might be an indirect target of BCOR, and that its expression is mediated by AP2a which controlled by BCOR.
While, the functional studies showed that BARX1 inhibited the mineralization and osteogenic differentiation marker, BSP in
MSCs. These findings indicate that BARX1 is a negative regulator for osteogenic differentiation in MSCs. Our previous study discovered that BCOR negatively regulates the osteogenic differentiation, and AP2a positively regulates the osteogenic differentiation in MSCs. 15 While in present study, BCOR upregulated the expression of BARX1, and AP2a downregulated the expression of BARX1. These results are consistent with our previous findings.
Moreover, by luciferase assay, as the partner of AP2a, YAP is found to enhance the inhibition of AP2a for the BARX1. And ChIP assay also showed that YAP prompts the recruitment of AP2a at its binding site in the BARX1 promoter, confirming that YAP could help AP2a to target BARX1 promoter and the inhibition of AP2a for the BARX1 transcript need YAP assisting. Interestingly, our results proofed that YAP also negatively regulated the expression of BAXR1, and functional study revealed that YAP inhibited osteogenic differentiation in MSCs. In skeletal lineage cells, previous investigation found that depletion both YAP and TAZ damaged the bone structures, matrix quality and caused fractures in vivo, inhibit osteogenic and collagen-related genes expression in vitro and in vivo. 45 Moreover, in some conditions, YAP activation could enhance the osteogenesis. [31] [32] [33] [34] These evidences indicated that YAP-mediated function and mechanism for osteogenic differentiation are complicated and suggested that regulation of YAP expression might not be a suitable method for controlling the directed differentiation, and interrupting the YAP partner or its protein complex formation may be the better way.
| CON CLUS ION
In the present study, our discoveries revealed that YAP protein could associate with RUNX2 or AP2a to form different protein complexes separately, AP2a competed with RUNX2 to recruit YAP by same PY domain in MSCs. AP2a/YAP complex directly downregulate the transcript of BARX1, which is a negative regulator for osteogenic differentiation in MSCs. Taken together, our discoveries suggested that AP2a may regulate the osteogenic differentiation in an indirect way through competing with RUNX2 to relieve the RUNX2 activity which inhibited by YAP, and also in a direct way via inhibiting the BARX1 in MSCs.
Thus, our discoveries shed new light to the mechanism of direct differentiation of MSCs and provide candidate targets for improving the osteogenic differentiation and enhancing bone tissue regeneration.
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